Home › Pharmacology › Dexamethasone and Betamethasone

Dexamethasone and Betamethasone

Dexamethasonum, Betamethasonum

For medical students2 min readUpdated 2026-10-10

Dexamethasone and betamethasone are synthetic long-acting fluorinated glucocorticosteroids. The presence of a fluorine atom in their molecular structure ensures maximum receptor affinity, making them the most potent anti-inflammatory drugs in their class.

StructureFluorinated derivatives of prednisolone with high receptor activity.

PotencyThe anti-inflammatory potency of dexamethasone exceeds that of prednisolone by 10 times.

DurationBoth agents produce pronounced and prolonged pharmacological effects.

AdministrationBetamethasone is primarily used topically as dermatological ointments and creams.

Pharmacodynamics of Fluorinated Glucocorticoids

The group of fluorinated cortisol derivatives includes dexamethasone, triamcinolone, and fludrocortisone. The addition of a fluorine atom to the molecule radically alters its properties, providing extremely high affinity for glucocorticoid receptors.

Due to this, dexamethasone exhibits the most potent anti-inflammatory effect among all glucocorticosteroids (GCS). The drug produces a prolonged systemic effect. A key distinction of dexamethasone is its specific impact on metabolism:

Mineral metabolism: practically causes no fluid retention due to minimal mineralocorticoid activity.
Protein metabolism: demonstrates powerful catabolic action (protein breakdown) surpassing prednisolone (similar in this regard to triamcinolone).

Because of active protein degradation, systemic dexamethasone is recommended primarily for short-term use—during periods of acute disease exacerbations or in cases of prednisolone intolerance.

Side Effects and Contraindications

In acute, life-threatening conditions, there are no absolute contraindications to dexamethasone. However, in elective therapy, the physician must weigh the benefit-risk ratio, considering relative contraindications:

Infections: tuberculosis, systemic mycoses, viral ocular and skin lesions.
Endocrine disorders: diabetes mellitus, osteoporosis.
Other conditions: hypertension, psychoses, glaucoma (even a history of it), and the administration of live vaccines.

Chronic use (especially at doses of 0.5–1 mg/day for more than one year) inevitably leads to severe adverse effects:

Endocrine disorders: development of exogenous Cushing's syndrome, growth retardation in children.
Fluid and electrolyte imbalance: hypokalemia (potassium loss) and sodium retention with water, leading to worsening arterial hypertension.
Musculoskeletal system and skin: osteoporosis (increased bone fragility), delayed wound healing due to reduced skin repair.
Metabolism and immunity: increased appetite, weight gain, high susceptibility to infections.

Topical and Inhalation Administration (Betamethasone and Beclomethasone)

Betamethasone is a synthetic, long-acting, fluorine-containing agent. Unlike dexamethasone, it is primarily used topically as ointments and creams. When applied to the skin or mucous membranes, absorption remains low, which minimizes the risk of systemic complications.

Indications for topical formulations: dermatitis, dermatoses, cutaneous manifestations of systemic diseases, and allergic pruritus. Systemic side effects are possible only with gross rule violations: using the drug longer than 4 weeks or applying it to more than 10% of the body surface area.

Beclomethasone is an inhaled GCS with virtually no systemic action.

Indications: steroid-dependent bronchial asthma (as an aerosol) and vasomotor rhinitis (intranasally).
Contraindications: first trimester of pregnancy, active pulmonary tuberculosis.
Local side effects: hoarseness, cough, throat irritation, sneezing, oral and respiratory candidiasis. A specific complication is paradoxical bronchospasm, treated with intravenous theophylline.

Mnemonic

To remember the profile of dexamethasone, use the "Maximum/Minimum" rule: Maximum anti-inflammatory and catabolic activity, Minimum effect on mineral metabolism (water retention).

Frequently asked questions

What is the pharmacokinetics of dexamethasone (absorption, plasma protein binding, half-life, and elimination pathways)?

The pharmacokinetics of dexamethasone includes low absorption with topical application, binding to transcortin, hepatic metabolism, and renal excretion. When applied to the skin or mucous membranes, drug absorption is low. Glucocorticoids have a high degree of plasma protein binding, with transcortin serving as their specific carrier. Inactivation occurs in the liver via conjugation, and metabolite excretion is carried out through the urine.

Half-life	Value (h)
From blood plasma	5
From tissues	36–54

What parenteral dosages of dexamethasone and betamethasone are used in emergency conditions?

Sources describe the parenteral use of dexamethasone for differentiation syndrome, whereas parenteral dosages for betamethasone are not presented; topical application in the form of ointments and creams is primarily indicated.

Dexamethasone (Dexamethasonum) — at the slightest suspicion of differentiation syndrome development, it is administered intravenously at a dose of 10 mg/m² twice daily until the syndrome resolves.
Betamethasone (Betamethasonum) — parenteral dosages are not presented in the sources; primarily topical application as ointments and creams is indicated.

Why is dexamethasone usually prescribed for short courses?

Due to its pronounced catabolic activity. The drug actively breaks down proteins, significantly surpassing prednisolone in this regard, so prolonged use leads to tissue depletion.

Are there any absolute contraindications for administering dexamethasone?

When prescribed for life-saving indications to manage acute conditions, absolute contraindications do not exist.

Under what conditions do betamethasone ointments cause systemic side effects?

The risk of systemic action increases manifold if the drug is applied to more than 10% of the body surface area or used continuously for longer than 4 weeks.

How is paradoxical bronchospasm from inhaled beclomethasone managed?

Intravenous administration of theophylline is used to relieve this specific complication.

Go deeper

Mechanism of development of exogenous Cushing's syndrome during long-term GCS therapy.
Impact of fluorinated glucocorticoids on protein metabolism and tissue repair.
Specifics of beclomethasone use in steroid-dependent bronchial asthma.
Relative contraindications to systemic GCS therapy: assessing the benefit-risk ratio.
Pathogenesis of hypokalemia induced by glucocorticosteroids.